From January 1, 2022 to March 31, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 44,857 shares, representing 0.39% for KRW 435.14 million under the buyback announced on March 27, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,560 KRW | +0.53% | -0.79% | -19.66% |
1st Jan change | Capi. | |
---|---|---|
-19.66% | 61.87M | |
+16.80% | 43.26B | |
+17.47% | 21.6B | |
+21.73% | 15.93B | |
+23.95% | 15.1B | |
+57.96% | 12.95B | |
-0.05% | 6.79B | |
-16.22% | 6.29B | |
+19.77% | 6.04B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A001540 Stock
- News Ahn-Gook Pharmaceutical Co., Ltd.
- Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.